Antibacterial Spectrum of a Tetrazole-Based Reversible Inhibitor of Serine β-Lactamases

Antimicrobial Agents and Chemotherapy
Orville A PembertonYu Chen

Abstract

CTX-M is the most prevalent family of extended-spectrum β-lactamases. We recently developed a tetrazole-derived noncovalent inhibitor of CTX-M-9. Here, we present the biochemical and microbiological activity of this inhibitor across a representative panel of serine β-lactamases and Gram-negative bacteria. The compound displayed significant activity against all major subgroups of CTX-M, including CTX-M-15, while it exhibited some low-level inhibition of other serine β-lactamases. Complex crystal structures with the CTX-M-14 S237A mutant and CTX-M-27 illustrate the binding contribution of specific active-site residues on the β3 strand. In vitro pharmacokinetic studies revealed drug-like properties and positive prospects for further optimization. These studies suggest that tetrazole-based compounds can provide novel chemotypes for future serine β-lactamase inhibitor discovery.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·Y H ChangJ H Richards
Sep 1, 1982·The Biochemical Journal·S G Waley
May 31, 2003·The Journal of Antimicrobial Chemotherapy·R BonnetJ Sirot
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·R Bonnet
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
Apr 25, 2007·Nucleic Acids Research·Ian W DavisDavid C Richardson
Dec 25, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G M RossoliniC Mugnaioli
May 6, 2008·Acta Crystallographica. Section D, Biological Crystallography·Thomas C TerwilligerLi-Wei Hung
Mar 24, 2009·Nature Chemical Biology·Yu Chen, Brian K Shoichet
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Sep 23, 2009·Acta Crystallographica. Section D, Biological Crystallography·Nigel W MoriartyPaul D Adams
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Karen Bush, George A Jacoby
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Akiko Shimizu-IbukaHiroshi Matsuzawa
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·T Geoff G BattyeAndrew G W Leslie
Feb 3, 2012·Journal of Medicinal Chemistry·Derek A NicholsYu Chen
Apr 10, 2012·Frontiers in Microbiology·Rafael CantónJuan Carlos Galán
Jan 29, 2014·Antimicrobial Agents and Chemotherapy·Nuno T AntunesSergei B Vakulenko
Dec 10, 2014·Biochemistry·Carolyn J AdamskiTimothy Palzkill
Mar 18, 2015·Journal of Medicinal Chemistry·Scott J HeckerMichael N Dudley
Jun 10, 2015·Journal of the American Chemical Society·Derek A NicholsYu Chen
Apr 1, 2016·Journal of Pharmaceutical Analysis·Mounyr BalouiriSaad Koraichi Ibnsouda

❮ Previous
Next ❯

Citations

Jun 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mahmoud A ElfakyHossam M Abdallah
Jun 7, 2019·Organic Chemistry Frontiers : an International Journal of Organic Chemistry·Kyle DeFreesAdam R Renslo
Sep 5, 2019·Journal of Medicinal Chemistry·Orville A PembertonYu Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.